美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ASPIRE BIOPHARMA HOLDINGS INC C/WTS 18/02/2030 (TO PUR COM)

0.0243

+0.002611.98%

成交量：1,548.00

成交額：33.46

市值：120.35萬

市盈率：-0.01

高：0.0243

開：0.0210

低：0.0210

收：0.0217

52周最高：0.0899

52周最低：0.0100

股本：4,952.60萬

流通股本：4,952.60萬

量比：0.23

換手率：0.00%

股息：- -

股息率：- -

每股收益(TTM):-1.6490

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

ASPIRE BIOPHARMA HOLDINGS INC C/WTS 18/02/2030 (TO PUR COM)

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.aspirebiolabs.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Aspire Biopharma Holdings, Inc.成立於2021年2月9日，是一家特拉華州公司。該公司是一家早期生物製藥公司，從事開發和營銷新型遞送機制顛覆性技術的業務，最初用於“不傷害”藥物。迄今為止，Aspire已開發並獲得了顛覆性技術，這些技術是一種新型可溶性製劑，旨在解決緊急情況、藥物功效、劑量管理和響應時間等問題。Aspire的重點是開發任何數量的可溶性、PH中性、速效粉末或顆粒形式的產品，允許產品的快速舌下吸收。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ASBPW/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ASBPW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ASBPW\",,,,,undefined,":{"symbol":"ASBPW","market":"US","secType":"STK","nameCN":"ASPIRE BIOPHARMA HOLDINGS INC C/WTS 18/02/2030 (TO PUR COM)","latestPrice":0.0243,"timestamp":1772733270524,"preClose":0.0217,"halted":0,"volume":1548,"delay":0,"changeRate":0.11981566820276489,"floatShares":49525975,"shares":49525975,"eps":-1.649,"marketStatus":"交易中","change":0.0026,"latestTime":"03-05 14:23:24 EST","open":0.021,"high":0.0243,"low":0.021,"amount":33.461098956,"amplitude":0.152074,"askPrice":0.0243,"askSize":51073,"bidPrice":0.021,"bidSize":15059,"shortable":0,"etf":0,"ttmEps":-1.649,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1772744400000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.0217,"volumeRatio":0.23005},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ASBPW\",,,,,undefined,":{"symbol":"ASBPW","floatShares":49525975,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.23005,"shares":49525975,"dividePrice":0,"high":0.0243,"amplitude":0.152074,"preClose":0.0217,"low":0.021,"week52Low":0.01,"pbRate":"--","week52High":0.0899,"institutionHeld":0,"latestPrice":0.0243,"committee":-0.544578,"eps":-1.649,"divideRate":0,"volume":1548,"delay":0,"ttmEps":-1.649,"open":0.021,"prevYearClose":0.0165,"prevWeekClose":0.018,"prevMonthClose":0.018,"prevQuarterClose":0.0165},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ASBPW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ASBPW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ASBPW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.aspirebiolabs.com","stockEarnings":[{"period":"1week","weight":0.0383},{"period":"1month","weight":-0.0441},{"period":"3month","weight":-0.2767},{"period":"6month","weight":-0.6036},{"period":"1year","weight":-0.6737},{"period":"ytd","weight":0.3152}],"compareEarnings":[{"period":"1week","weight":-0.0116},{"period":"1month","weight":-0.0148},{"period":"3month","weight":0.0011},{"period":"6month","weight":0.0585},{"period":"1year","weight":0.1877},{"period":"ytd","weight":0.0047}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Aspire Biopharma Holdings, Inc.成立於2021年2月9日，是一家特拉華州公司。該公司是一家早期生物製藥公司，從事開發和營銷新型遞送機制顛覆性技術的業務，最初用於“不傷害”藥物。迄今為止，Aspire已開發並獲得了顛覆性技術，這些技術是一種新型可溶性製劑，旨在解決緊急情況、藥物功效、劑量管理和響應時間等問題。Aspire的重點是開發任何數量的可溶性、PH中性、速效粉末或顆粒形式的產品，允許產品的快速舌下吸收。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.250363},{"month":2,"riseRate":0.25,"avgChangeRate":-0.17505},{"month":3,"riseRate":0.75,"avgChangeRate":0.043305},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.189666},{"month":5,"riseRate":0.25,"avgChangeRate":0.104929},{"month":6,"riseRate":0.5,"avgChangeRate":0.091088},{"month":7,"riseRate":1,"avgChangeRate":0.346849},{"month":8,"riseRate":0.25,"avgChangeRate":-0.086693},{"month":9,"riseRate":0,"avgChangeRate":-0.285022},{"month":10,"riseRate":0.5,"avgChangeRate":-0.10154},{"month":11,"riseRate":0,"avgChangeRate":-0.353081},{"month":12,"riseRate":0.75,"avgChangeRate":0.887235}],"exchange":"NASDAQ","name":"ASPIRE BIOPHARMA HOLDINGS INC C/WTS 18/02/2030 (TO PUR COM)","nameEN":"ASPIRE BIOPHARMA HOLDINGS INC C/WTS 18/02/2030 (TO PUR COM)"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ASBPW\",market:\"US\",,,undefined,":null}}